JWA
AMED

JFS Wealth Advisors’s Amedisys AMED Stock Holding History

JFS Wealth Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14
Closed -$1.38K – 1903
2025
Q2 		$1.38K Sell
14
-122
-90% -$11.5K ﹤0.01% 1492
2025
Q1 		$12.6K Hold
136
– – ﹤0.01% 804
2024
Q4 		$12.3K Hold
136
– – ﹤0.01% 791
2024
Q3 		$13.1K Hold
136
– – ﹤0.01% 762
2024
Q2 		$12.5K Hold
136
– – ﹤0.01% 724
2024
Q1 		$12.5K Hold
136
– – ﹤0.01% 745
2023
Q4 		$12.9K Hold
136
– – ﹤0.01% 700
2023
Q3 		$12.7K Hold
136
– – ﹤0.01% 649
2023
Q2 		$12.4K Buy
136
+8
+6% +$656 ﹤0.01% 666
2023
Q1 		$9.41K Sell
128
-8
-6% -$692 ﹤0.01% 736
2022
Q4 		$11.4K Sell
136
-6
-4% -$541 ﹤0.01% 663
2022
Q3 		$14K Buy
142
+14
+11% +$1.67K ﹤0.01% 635
2022
Q2 		$13K Sell
128
-10
-7% -$1.28K ﹤0.01% 684
2022
Q1 		$24K Buy
138
+10
+8% +$1.49K ﹤0.01% 557
2021
Q4 		$21K Buy
128
+6
+5% +$964 ﹤0.01% 555
2021
Q3 		$18K Buy
+122
New +$25.4K ﹤0.01% 554

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JFS Wealth Advisors's AMED Position: Q3 2025 in Review

JFS Wealth Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14 shares — an estimated $1.38K sold.

JFS Wealth Advisors first reported a position in AMED in Q3 2021 and held it in 16 quarters. The position peaked at $24K in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • JFS Wealth Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • JFS Wealth Advisors sold 14 Amedisys shares in Q3 2025, an estimated $1.38K.
  • JFS Wealth Advisors first reported a position in Amedisys in Q3 2021 and held it in 16 quarters.
  • JFS Wealth Advisors's Amedisys position peaked at $24K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on JFS Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.